Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02761837 · ClinicalTrials.gov registry record · NA
The Breathe Well Program for Adults With Asthma
A NA study of Asthma, sponsored by National Jewish Health.
- Completed
- Registry status
- NA
- Development phase
- 14,978
- Enrollment target
- 1
- Study location
NCT02761837: Completed NA study of Asthma, sponsored by National Jewish Health.
NCT02761837 is a NA study of Asthma that has completed, run by National Jewish Health. The registered enrollment target is 14,978 participants, above the 1,523-participant average among 374 other Asthma trials with a reported enrollment target (883% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02761837, a NA study of Asthma, has completed, sponsored by National Jewish Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 14,978 participants
- Enrollment target
- 1
- Study location
Study Summary
The Breathe Well Study is a pragmatic, controlled trial to assess the effectiveness, cost-effectiveness, and implementation of the Breathe Well intervention, which combines evidence-based EHR and interactive behavior-change technologies (IBCT) and team-based care to improve asthma outcomes.
Primary Outcome
Defined as number of urgent care visits, hospitalizations, or prescriptions of an oral corticosteroid
Conditions Studied
Interventions
- BEHAVIORAL Email
- BEHAVIORAL IVR call/text
Study Locations (1)
Colorado
- Kaiser Permanente of Colorado - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14,978 participants |
| Start Date | 2016-10 |
| Est. Completion | 2023-06 |
| Phase | NA |
What the finished NCT02761837 record still lists
NCT02761837 is an interventional study that assigns participants to a tested intervention. Its 14,978 participants enrollment target places it among the larger protocols in the corpus, above the 1,523-participant average among 374 other Asthma trials with a reported enrollment target (883% higher).
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Email is the first listed.
NCT02761837 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT02761837 about?
NCT02761837 is a clinical study titled "The Breathe Well Program for Adults With Asthma". The Breathe Well Study is a pragmatic, controlled trial to assess the effectiveness, cost-effectiveness, and implementation of the Breathe Well intervention, which combines evidence-based EHR and interactive behavior-change technologies (IBCT) and team-based care to improve asthma outcomes.
What is the current status of trial NCT02761837?
This trial is currently completed. It is a NA study. The enrollment target is 14,978 participants. The study started on 2016-10. Estimated completion is 2023-06.
What conditions does trial NCT02761837 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT02761837?
The interventions under investigation include: Email (BEHAVIORAL), IVR call/text (BEHAVIORAL).
Who is sponsoring clinical trial NCT02761837?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02761837 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02761837's enrollment target sits among peer trials
14,978 8th of 374 higher than 367 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00857922 · 15,000 participants
Neurosciences Research Repository
- NCT01137643 · 15,000 participants
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
- NCT01550575 · 15,000 participants
Patient Retrospective Outcomes (PRO)
- NCT02253251 · 15,000 participants
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia